Allarity Therapeutics (ALLR) Reports Key Progress in Phase 2 Stenoparib Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. ESTC
2. WDAY
3. MRVL
4. AFRM
5. RBRK
6. S
7. NVDA
8. DG
9. ULTA
10. GAP

Go back to Allarity Therapeutics (ALLR) Reports Key Progress in Phase 2 Stenoparib Trial
(NASDAQ: ALLR) Delayed: 1.41 --0 (-0%)
Previous Close $1.41    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.41    P/E N/A 
Day Low $1.41    EPS $ 
Volume 158